Drug Development Pharma - August 22, 2016
Lundbeck’s Idalopirdine granted Fast Track Designation
Lundbeck and Otsuka Pharmaceutical Development & Commercialization has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to the investigational agent idalopirdine for the treatment of mild to moderate Alzheimer’s disease. Idalopirdine is a selective 5HT6 receptor antagonist with a different hypothesized mechanism of action than currently available Alzheimer’s medications. […]
Pharma Business - August 20, 2015
Major restructuring at Lundbeck
Lundbeck A/S has announced a new restructuring programme in order to significantly improve profitability and improve the company’s value creation. Lundbeck expects that this restructuring programme will affect approximately 1,000 employees. Lundbeck needs higher profitability to be able to invest in future profitable growth initiatives leading to better treatments for patients and secure a competitive […]
Clinical Trials - August 13, 2015
Findings from the QUALIFY study
Otsuka Pharmaceutical and Lundbeck has announced that a newly released subgroup analysis of data from the QUALIFY study showed significantly greater and clinically meaningful improvements in functioning and health-related quality of life with aripiprazole once-monthly compared with paliperidone palmitate in patients aged 18-35 years living with schizophrenia 1. “These latest findings from the QUALIFY study […]
Clinical Trials - July 25, 2015
Drug Tested for Rare Epilepsy
Lundbeck LLC has initiated the CLOVER I Study to investigate the use of clobazam for the treatment of children and adolescents with Dravet syndrome — a rare and severe form of epilepsy that begins in infancy. The drug already is approved in the U.S. for seizures associated with another epilepsy syndrome. The study is designed […]
Companies - June 4, 2015
Lundbeck Urges Alcohol Curbs
Danish drugmaker Lundbeck, which markets the alcoholism drug Selincro, last month mobilized members of the European Parliament, anti-alcohol NGOs and academics to convince the European Parliament to vote to urge the European Commission to take a harder position against the detrimental affects of alcohol. Lundbeck employees also quietly ran anti-alcohol campaigns behind the scenes, Politico […]
Companies - May 19, 2015
Lundbeck, Others Call for MDD in Dictionaries
A petition supported byTakeda Pharmaceuticals U.S.A., Inc. and Lundbeck U.S. calls on popular dictionaries, including Oxford Dictionary and Dictionary.com, to consider including Major Depressive Disorder (MDD) and all of the symptoms associated with it in their dictionaries. The goal of the petition is to bring greater awareness to the disorder and its symptoms. The word […]
